These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 9883066)

  • 1. [Hypertension and dyslipidemia].
    de Lombera Romero F; Fernández Casares S; Gascueña Rubia R; Lázaro M; Hernández Simón P; Saavedra Falero J; Sánchez Sánchez V; Velázquez Martín MT; García Pascual J; Sáenz de la Calzada C
    Rev Esp Cardiol; 1998; 51 Suppl 4():24-35. PubMed ID: 9883066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the deadly quartet.
    Deedwania PC
    Can J Cardiol; 2000 Aug; 16 Suppl E():17E-20E. PubMed ID: 10906620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin resistance and hyperinsulinemia--clinical aspects].
    Kozek E
    Przegl Lek; 1996; 53(9):647-52. PubMed ID: 8992530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR; Gokce N
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice].
    Couderc R; Maachi M
    Ann Biol Clin (Paris); 1999; 57(2):157-67. PubMed ID: 10210742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension and dyslipidemia.
    Jazra C
    J Med Liban; 2000; 48(6):364-9. PubMed ID: 11503527
    [No Abstract]   [Full Text] [Related]  

  • 8. [Major nutrition-related risk factors of ischemic heart disease: dyslipoproteinemia, obesity, hypertension, glucose intolerance].
    Pados G
    Orv Hetil; 1999 Jul; 140(28):1563-72. PubMed ID: 10443132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension: a new perspective in therapy and metabolic effect. Part I.
    Medina Ruiz A
    Bol Asoc Med P R; 1991 Sep; 83(9):399-401. PubMed ID: 1807274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease.
    Johnson ML; Pietz K; Battleman DS; Beyth RJ
    Am J Manag Care; 2004 Dec; 10(12):926-32. PubMed ID: 15617368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis: a major cause of peripheral vascular disease.
    Fagan-Dubin L
    Nurs Clin North Am; 1977 Mar; 12(1):101-8. PubMed ID: 585006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for arteriosclerosis].
    Henzen C
    Praxis (Bern 1994); 2001 Jan; 90(4):91-5. PubMed ID: 11213573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction and type 2 diabetes. Part 1: physiology and methods for exploring the endothelial function.
    Guerci B; Kearney-Schwartz A; Böhme P; Zannad F; Drouin P
    Diabetes Metab; 2001 Sep; 27(4 Pt 1):425-34. PubMed ID: 11547216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is insulin resistance atherogenic? A review of the evidence.
    Ferrannini E; Iozzo P
    Atheroscler Suppl; 2006 Aug; 7(4):5-10. PubMed ID: 16824807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic predictors of hypertension.
    Haffner SM
    J Hypertens Suppl; 1999 Aug; 17(3):S23-8. PubMed ID: 10489095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
    Caballero AE
    Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapy.
    Chapman MJ; Sposito AC
    Pharmacol Ther; 2008 Mar; 117(3):354-73. PubMed ID: 18215759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes--including reducing the risk of age and atherosclerosis.
    Hellstrom HR
    Med Hypotheses; 2007; 68(2):415-33. PubMed ID: 16828234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.